EEF2 anticorps (AA 2-858)
Aperçu rapide pour EEF2 anticorps (AA 2-858) (ABIN7151548)
Antigène
Voir toutes EEF2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 2-858
-
Réactivité croisée
- Humain
-
Purification
- >95%, Protein G purified
-
Immunogène
- Recombinant Human Elongation factor 2 protein (2-858AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- EEF2 (Eukaryotic Translation Elongation Factor 2 (EEF2))
-
Autre désignation
- EEF2
-
Sujet
-
Background: Catalyzes the GTP-dependent ribosomal translocation step during translation elongation. During this step, the ribosome changes from the pre-translocational (PRE) to the post-translocational (POST) state as the newly formed A-site-bound peptidyl-tRNA and P-site-bound deacylated tRNA move to the P and E sites, respectively. Catalyzes the coordinated movement of the two tRNA molecules, the mRNA and conformational changes in the ribosome.
Aliases: EEF 2 antibody, Eef2 antibody, EF-2 antibody, EF2 antibody, EF2_HUMAN antibody, Elongation factor 2 antibody, Eukaryotic translation elongation factor 2 antibody, Polypeptidyl tRNA translocase antibody, SCA26 antibody
-
UniProt
- P13639
-
Pathways
- AMPK Signaling
Antigène
-